Skip to content

Intranasal Dexmedetomidine VS Oral Chloral Hydrate for Rescue Sedation During Magnetic Resonance Imaging

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02239445
Enrollment
158
Registered
2014-09-12
Start date
2014-09-30
Completion date
2015-05-31
Last updated
2015-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Administration Related Reaction, Chloral Hydrate Adverse Reaction, Failed Moderate Sedation During Procedure

Brief summary

The purpose of this investigation was to test the hypothesis that intranasal dexmedetomidine is as effective as second dose of oral chloral hydrate for rescue sedation in infant age between 1 and 6 months who were not adequately sedated following initial dose of chloral hydrate.

Interventions

DRUGchloral hydrate Group

chloral hydrate 0.25 mg/kg oral solution diluted with oral syrup to 5 ml and 0.2 mL intranasal placebo (normal saline)

DRUGlow dose dexmedetomidine group

Group L received intranasal dexmedetomidine at 1mcg/kg and 5 ml oral syrup

DRUGhigh dose dexmedetomidine group

Group H received intranasal dexmedetomidine at 2mcg/kg and 5 ml oral syrup

Sponsors

Guangzhou Women and Children's Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
DOUBLE (Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
1 Months to 6 Months
Healthy volunteers
No

Inclusion criteria

* 160 children of ASA physical status I or II, aged between 1 and 6 months, failed chloral hydrate sedation during MRI scanning

Exclusion criteria

* known allergy or hypersensitive reaction to dexmedetomidine or CH, organ dysfunction, pneumonia, acute upper respiratory airway inflammation, preterm, cardiac arrhythmia or and congenital heart disease.

Design outcomes

Primary

MeasureTime frameDescription
successful rescue sedation rateup to 1 hours after MRI scaningSedation status was evaluated by a attending anesthesiologists every 5-10 min with a 6-point sedation scale, which was modified from the Observer Assessment of Alertness and Sedation Scale (MOAA/S; Table 1). successful sedation was defined as an MOAA/S of between 0 and 3

Secondary

MeasureTime frameDescription
sedation induction timeup to 30 min after rescue drug administrationSuccessful sedation was defined as an MOAA/S of between 0 and 2, and sedation induction time was defined as the time from rescue drug administration to the onset of satisfactory sedation 0 Does not respond to a noxious stimulus 1. Does not respond to mild prodding or shaking 2. Responds only after mild prodding or shaking 3. Responds only after name is called loudly orrepeatedly 4. Lethargic response to name spoken in normal tone 5. Appears asleep, but responds readily to namespoken in normal tone 6. Appears alert and awake, responds readily to namespoken in normal tone
Wake -up timeup to 4 hours after rescue drug administrationChildren were classified as awake if the MOAA/S was between 4 and 6. Wake -up time was defined as the time from successful sedation until the time that the child awoke

Other

MeasureTime frameDescription
non-invasive systolic blood pressurebaseline, before and 15 , 30, 60, 75, 90 min after rescue drug administrationchanges in the non-invasive systolic blood pressure at the baseline, before and 15 , 30, 60, 75, 90 min after rescue drug administration
heart ratebaseline, before and 15 , 30, 60, 75, 90 min after rescue drug administrationchanges in heart rates at the baseline, before and 15 , 30, 60, 75, 90 min after rescue drug administration
Oxyhemoglobin desaturationbaseline and four hours after rescue medicine administrationSignificant Oxyhemoglobin desaturation was defined as\<94%

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026